Award Year / Program / Phase:2001 / SBIR / Phase I
Agency:HHS
Principal Investigator:Pazhani Sundaram
Award Amount:$122,437.00
Abstract:
DESCRIPTION (provided by applicant): Protein-protein interactions are central
to the process of signal transduction in biological systems. Transmembrane
receptor tyrosine kinase (RTKs) play important roles in many aspects of cell
growth and behavior. Activated RTKs,… More
DESCRIPTION (provided by applicant): The long-term goal is to develop an effective therapy for Alzheimer's disease, by using a subcutaneous hydrogel to recognize, concentrate and eliminate beta-amyloid (Abeta) peptides and thereby halt deposition of plaque in the brain. The hydrogel forms in situ… More
DESCRIPTION (provided by applicant): The neurotoxic amyloid plaques in the brain, characteristic of Alzheimer's disease (AD), are formed by aggregation of 2 overlapping fragments (AB1-40 and AB1-42) of the amyloid precursor protein. These A-beta peptides can cross the blood-brain barrier. Our… More
Award Year / Program / Phase:2008 / SBIR / Phase I
Agency:HHS
Principal Investigator:
Award Amount:$351,027.00
Abstract:
DESCRIPTION (provided by applicant): The hallmark of Alzheimer's disease (AD) is the presence in brain of plaques, which are complex extracellular lesions composed of a central deposition of 2-amyloid peptide. Genetic, neuropathological and biochemical evi
dence have shown that these deposits play… More
DESCRIPTION (provided by applicant): ABSTRACT The objective of our research is to develop an effective therapy for Alzheimer's disease (AD), by using an approach that is able to concentrate, bind and eliminate -amyloid peptides and thereby delay
and or halt deposition of plaque in the… More